TY  - JOUR
T1  - Chromophobe renal cell carcinoma: Comprehensive analysis of 11 cases
A1  - Rajendra Nerli
A1  - Swapnil Pattanshetti
A1  - Shridhar Ghagane
A1  - P Malur
JF  - Clinical Cancer Investigation Journal
JO  - Clin Cancer Investig J
SN  - 2278-0513
Y1  - 2015
VL  - 4
IS  - 1
DO  - 10.4103/2278-0513.149023
SP  - 9
EP  - 12
N2  - Background: Chromophobe renal cell carcinoma (chRCC) is a subtype of RCC. chRCC is diagnosed mainly in sixth decade of life. An incidence of chRCC is similar in both men and woman. Eighty-six percent of chRCCs cases are diagnosed in early stages. To analyze the clinical behavior of chRCC, we retrospectively evaluated the data from our hospital. The aim of this study was to evaluate the incidence, clinical presentation, prognosis, and clinical outcome of chRCC in a retrospective series of nephrectomy specimens. Materials and Methods: We retrospectively looked at our hospital database, which included 318 patients who had undergone surgery for RCC between January 2000 and December 2013. Several parameters were noted in each patient, which included age, sex, symptoms at presentation, Eastern Cooperative Oncology Group performance status, tumor diameter, tumor node metastasis stage and grade, histologic cell type, follow-up time, local recurrence, disease progression, and death. Results: Of 318 patients included in the database, 11 (3.45%) had chRCC. Preoperatively, 9 (81%) had T1 lesions, and the remaining 2 (18.9%) had T2 lesions. Of the T1 lesions, 6 had tumors ≤4 cm (T1a) in diameter and the remaining 3 had tumors >4 cm (T1b) in diameter. The mean survival of the patients was 99.27 ΁ 27 months. Conclusions: Our series confirms a favorable outcome for the chRCC subtype with little local aggressiveness and a low propensity for progression and death from cancer.
UR  - https://ccij-online.org/article/chromophobe-renal-cell-carcinoma:-comprehensive-analysis-of-11-cases-334
ER  -